Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Current-Deferred-Revenue" stands at 18.63 Billion Japanese Yens as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -84.35 percent compared to the value the year prior.
The 1 year change in percent is -84.35.
The 3 year change in percent is -86.21.
The 5 year change in percent is -84.10.
The 10 year change in percent is -77.84.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |